IL-2 Plasmid Electroporation: From Preclinical Studies to Phase I Clinical Trial
Electroporation (EP)-assisted intralesional delivery of Interleukin-2 (IL-2) plasmid (pDNA) has the potential to increase the local concentration of the expressed cytokine for an extended time in the injected tumors while minimizing its systemic concentration, in comparison with systemic delivery of the recombinant cytokine. Nonclinical Investigational New Drug application-enabling studies were performed in mice to evaluate the effect of intratumoral administration of murine IL-2 pDNA on local expression and systemic distribution of IL-2 transgene as well as the inhibition of established tumor growth. The safety of repeated administrations of a human IL-2 pDNA product candidate with EP was evaluated in rats. Following the nonclinical safety and efficacy studies, a human IL-2 pDNA product candidate intralesionally administered with EP to metastatic melanoma patients is currently being investigated in a phase I clinical trial.
- 相差干涉显微镜 differential interferencemicroscope
- 植物生理学 plant physiology
- 乔木线 timber line, timber limit
- 生态分布 ecological distribution
- Measuring Electroosmotic Flow in Microchips and Capillaries
- 二倍体化 diploidization
- 出菌率(平板效率) plating efficiency
- 伤害刺激 noxious stimulus
- 半乳糖-1-磷酸 galactose-1-phosphate
- 感觉的特殊能量法则 law of specific energyof sense